These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 35203552)

  • 1. Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases.
    Yeo XY; Cunliffe G; Ho RC; Lee SS; Jung S
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of neuropeptide drugs that cross the blood-brain barrier.
    Egleton RD; Davis TP
    NeuroRx; 2005 Jan; 2(1):44-53. PubMed ID: 15717056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant neuropeptides as drug leads for neurological diseases.
    Robertson CR; Flynn SP; White HS; Bulaj G
    Nat Prod Rep; 2011 Apr; 28(4):741-62. PubMed ID: 21340067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal delivery of neurotherapeutics
    Rajput A; Pingale P; Dhapte-Pawar V
    Front Pharmacol; 2022; 13():979682. PubMed ID: 36176429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases.
    Holm A; Hansen SN; Klitgaard H; Kauppinen S
    RNA Biol; 2022; 19(1):594-608. PubMed ID: 35482908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.
    Correia AC; Monteiro AR; Silva R; Moreira JN; Sousa Lobo JM; Silva AC
    Adv Drug Deliv Rev; 2022 Oct; 189():114485. PubMed ID: 35970274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability and transport of peptides and peptide drugs into the brain.
    Egleton RD; Davis TP
    Peptides; 1997; 18(9):1431-9. PubMed ID: 9392847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.
    Zhou X; Smith QR; Liu X
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1695. PubMed ID: 33470550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders.
    Alajangi HK; Kaur M; Sharma A; Rana S; Thakur S; Chatterjee M; Singla N; Jaiswal PK; Singh G; Barnwal RP
    Mol Brain; 2022 Jun; 15(1):49. PubMed ID: 35650613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective drug delivery approaches to lesioned brain through blood brain barrier disruption.
    Al-Ahmady ZS
    Expert Opin Drug Deliv; 2018 Apr; 15(4):335-349. PubMed ID: 29466890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the blood-brain barrier during neurological disease and infection.
    Patabendige A; Janigro D
    Biochem Soc Trans; 2023 Apr; 51(2):613-626. PubMed ID: 36929707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A TfR-Binding Cystine-Dense Peptide Promotes Blood-Brain Barrier Penetration of Bioactive Molecules.
    Crook ZR; Girard E; Sevilla GP; Merrill M; Friend D; Rupert PB; Pakiam F; Nguyen E; Yin C; Ruff RO; Hopping G; Strand AD; Finton KAK; Coxon M; Mhyre AJ; Strong RK; Olson JM
    J Mol Biol; 2020 Jun; 432(14):3989-4009. PubMed ID: 32304700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
    Teixeira MI; Lopes CM; Amaral MH; Costa PC
    Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Factors and Adult Neurogenesis: Impacts of Chinese Herbal Medicine on Brain Repair in Neurological Diseases.
    Gao C; Shen J
    Int Rev Neurobiol; 2017; 135():117-147. PubMed ID: 28807156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptides and small-molecule amine transmitters: cooperative signaling in the nervous system.
    Eiden LE; Hernández VS; Jiang SZ; Zhang L
    Cell Mol Life Sci; 2022 Aug; 79(9):492. PubMed ID: 35997826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards standardization of the parameters for opening the blood-brain barrier with focused ultrasound to treat glioblastoma multiforme: A systematic review of the devices, animal models, and therapeutic compounds used in rodent tumor models.
    Thombre R; Mess G; Kempski Leadingham KM; Kapoor S; Hersh A; Acord M; Kaovasia T; Theodore N; Tyler B; Manbachi A
    Front Oncol; 2022; 12():1072780. PubMed ID: 36873300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors of peptides as therapeutic targets in epilepsy research.
    Dobolyi A; Kékesi KA; Juhász G; Székely AD; Lovas G; Kovács Z
    Curr Med Chem; 2014; 21(6):764-87. PubMed ID: 24251562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional morphology of the blood-brain barrier in health and disease.
    Liebner S; Dijkhuizen RM; Reiss Y; Plate KH; Agalliu D; Constantin G
    Acta Neuropathol; 2018 Mar; 135(3):311-336. PubMed ID: 29411111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
    Hoyer D; Bartfai T
    Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy.
    Fernandez M; Nigro M; Travagli A; Pasquini S; Vincenzi F; Varani K; Borea PA; Merighi S; Gessi S
    Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.